1. Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization 
Yanping Kuang, M.D., Qiuju Chen, Ph.D., Yonglun Fu, M.D., Yun Wang, M.D., Qingqing Hong, M.D., Qifeng Lyu, Ph.D., Ai Ai, M.D., Zeev Shoham, M.D. 
Fertility and Sterility 
Volume 104, Issue 1, Pages e3 (July 2015)
DOI: /j.fertnstert
Copyright © 2015 American Society for Reproductive Medicine Terms and Conditions

2. Figure 1
Serum hormone profiles present during ovarian stimulation using the MPA cotreatment protocol. The arrows point to significant changes in the values at different points in time (P<.05).
Fertility and Sterility  , e3DOI: ( /j.fertnstert )
Copyright © 2015 American Society for Reproductive Medicine Terms and Conditions

3. Supplemental Figure 1 Study flowchart.
Fertility and Sterility  , e3DOI: ( /j.fertnstert )
Copyright © 2015 American Society for Reproductive Medicine Terms and Conditions

4. Supplemental Figure 2
Scatterplot of serum hormones on the trigger day and the day after trigger in the MPA cotreatment group. Green circles represent the subgroup of patients triggered by GnRHa 0.1 mg. Blue circles represent the subgroup of patients triggered by GnRHa 0.1 mg and hCG 1,000 IU.
Fertility and Sterility  , e3DOI: ( /j.fertnstert )
Copyright © 2015 American Society for Reproductive Medicine Terms and Conditions